Key Insights

Highlights

Success Rate

43% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 55/100

Termination Rate

44.4%

4 terminated out of 9 trials

Success Rate

42.9%

-43.6% vs benchmark

Late-Stage Pipeline

44%

4 trials in Phase 3/4

Results Transparency

100%

3 of 3 completed with results

Key Signals

3 with results43% success

Data Visualizations

Phase Distribution

6Total
P 2 (2)
P 3 (3)
P 4 (1)

Trial Status

Terminated4
Completed3
Withdrawn1
Active Not Recruiting1

Trial Success Rate

42.9%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (9)

Research Network

Activity Timeline